Brief: Suven Life Sciences gets product patent in Japan
21/08/2017 06:40
Aug 21 (Reuters) - Suven Life Sciences Ltd SUVP.NS
* Suven life sciences secures a product patent in japan
* Patent for new chemical entities for the treatment of
disorders associated with neurodegenerative diseases
* Says patents are valid through 2034
Source text for Eikon: ID:nBSEbhhnmy
Further company coverage: SUVP.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Patient Enrollment In Global Phase-3 Masupirdine Study
India's Suven Life Sciences gains after Masupirdine Phase-3 study completes patient enrollment
Brief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant